Table 3.
Thematic Top Three Most Commonly Cited Criteria by Geographic Region
| Specific Criteria | Citations | All Articles, n | North America, n (%) | Europe, n (%) | Asia, n (%) | Other, n (%) |
|---|---|---|---|---|---|---|
| Patient | ||||||
| Patients or families who decline intensive care or some of its components | (36, 37, 44, 50, 55, 59, 73, 94, 105, 127, 133) (1, 19, 30, 47, 53, 56, 66–68, 93, 102, 103, 117–119, 125, 136, 140) | 29 | 10 (16) | 14 (30) | 4 (33) | 1 (14) |
| Bedridden | (47, 53, 79, 109, 129) | 5 | 0 (0) | 5 (11) | 0 (0) | 0 (0) |
| Advanced age | (23, 62, 69, 111) | 4 | 1 (2) | 3 (9) | 0 (0) | 0 (0) |
| Condition | ||||||
| No further oncological treatment options | (20, 47, 48, 53, 56, 66, 77, 79, 113, 118, 129, 133) | 12 | 2 (3) | 8 (17) | 2 (17) | 0 (0) |
| Persistent vegetative state | (39, 66, 82, 103, 115, 117, 118, 133) | 8 | 6 (9) | 1 (2) | 1 (8) | 0 (0) |
| Terminal diagnosis | (20, 35, 87, 100, 109, 118, 119, 133) | 8 | 4 (6) | 2 (4) | 2 (17) | 0 (0) |
| Physician | ||||||
| Too well | (15, 16, 26, 32, 45, 50, 62, 63, 66–69, 87, 95, 98, 110, 112, 125, 136, 138, 141) | 21 | 8 (13) | 9 (20) | 1 (8) | 3 (43) |
| Too sick | (15, 16, 26, 32, 50, 62, 63, 67–69, 95, 98, 101, 112, 138, 141) | 16 | 6 (10) | 7 (15) | 1 (8) | 2 (29) |
| Likelihood of benefit | (25, 31, 66, 103, 133, 135, 139, 141) | 8 | 3 (5) | 3 (7) | 2 (17) | 0 (0) |
| Context | ||||||
| Metastatic | (17, 27, 40, 41, 65, 70, 74, 75, 89–91, 95, 104, 131, 137) | 15 | 9 (14) | 4 (9) | 1 (8) | 1 (14) |
| Advanced and irreversible neurologic event or condition | (17, 27, 40, 41, 65, 70, 74, 75, 90, 91, 95, 124, 131, 137) | 14 | 8 (13) | 4 (9) | 1 (8) | 1 (14) |
| Sequential Organ Failure Assessment score > 11 | (17, 27, 40, 46, 70, 75, 90, 91, 95, 104, 124, 131) | 12 | 6 (9) | 5 (9) | 1 (8) | 0 (0) |